| Gujarat Terce Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524314 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE499G01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 10.09 |
Market Cap(₹Cr) : 35.53 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.93 | 10.85 | 12.32 | 12.68 | 13.30 | 11.89 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.93 | 10.85 | 12.32 | 12.68 | 13.30 | 11.89 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.06 | 0.09 | 0.09 | 0.07 | 0.08 | 0.07 |
| Total Income | 12.98 | 10.95 | 12.41 | 12.75 | 13.38 | 11.96 |
| Total Expenditure | 11.04 | 10.87 | 11.27 | 11.59 | 11.64 | 11.81 |
| PBIDT | 1.94 | 0.07 | 1.14 | 1.16 | 1.74 | 0.15 |
| Interest | 0.07 | 0.05 | 0.07 | 0.08 | 0.13 | 0.13 |
| PBDT | 1.88 | 0.03 | 1.07 | 1.07 | 1.61 | 0.02 |
| Depreciation | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 |
| Tax | 0.44 | 0.00 | 3.58 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.06 | -0.03 | 0.78 | -0.03 | 0.03 | 0.01 |
| Reported Profit After Tax | 1.40 | -0.04 | -3.39 | 1.01 | 1.48 | -0.08 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 1.40 | -0.04 | -3.39 | 1.01 | 1.48 | -0.08 |
| EPS (Unit Curr.) | 1.89 | -0.06 | -4.57 | 1.36 | 2.00 | -0.10 |
| EPS (Adj) (Unit Curr.) | 1.89 | -0.06 | -4.57 | 1.36 | 2.00 | -0.10 |
| Calculated EPS (Unit Curr.) | 1.89 | -0.06 | -4.57 | 1.36 | 2.00 | -0.10 |
| Calculated EPS (Adj) (Unit Curr.) | 1.89 | -0.06 | -4.57 | 1.36 | 2.00 | -0.10 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.57 | -0.23 | -18.28 | 5.43 | 7.99 | -0.42 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.57 | -0.23 | -18.28 | 5.43 | 7.99 | -0.42 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 | 7.42 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 15.00 | 0.65 | 9.25 | 9.15 | 13.08 | 1.26 |
| PBDTM(%) | 14.54 | 0.28 | 8.69 | 8.44 | 12.11 | 0.17 |
| PATM(%) | 10.83 | -0.37 | -27.52 | 7.97 | 11.13 | -0.67 |